Identification and Analysis of in Vivo VEGF Downstream Markers Link VEGF Pathway Activity With Efficacy of Anti-Vegf Therapies

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-12-3635
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Anti-Vegf Therapies in the Clinic

Cold Spring Harbor perspectives in medicine
BiochemistryMedicineGeneticsMolecular Biology
2012English

Anti-Vascular Therapies in Ovarian Cancer: Moving Beyond Anti-Vegf Approaches

Cancer and Metastasis Reviews
Cancer ResearchOncology
2014English

Modeling Bad Behavior: Overcoming Anti-Vegf Resistance in Vivo

Gynecologic Oncology
GynecologyOncologyObstetrics
2016English

Genetic Biomarkers in the VEGF Pathway Predicting Response to Anti-Vegf Therapy in Age-Related Macular Degeneration

BMJ Open Ophthalmology
Ophthalmology
2019English

Unique Signal Transduction of the VEGF Family Members VEGF-A and VEGF-E

Biochemical Society Transactions
Biochemistry
2009English

Expression Analysis of VEGF-A and VEGF-B: Relationship With Clinicopathological Parameters in Bladder Cancer

Oncology Reports
MedicineCancer ResearchOncology
2009English

Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-Vegf Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2003English

Anti-Angiogenic Alternatives to VEGF Blockade

Clinical and Experimental Metastasis
MedicineCancer ResearchOncology
2015English

Ocular Anti-Vegf Therapy for Diabetic Retinopathy: The Role of VEGF in the Pathogenesis of Diabetic Retinopathy

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy